Hurt R D, Offord K P, Croghan I T, Croghan G A, Gomez-Dahl L C, Wolter T D, Dale L C, Moyer T P
Nicotine Research Center, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
Psychopharmacology (Berl). 1998 Nov;140(1):98-104. doi: 10.1007/s002130050744.
Nicotine nasal spray and nicotine gum have been found to be effective in relieving nicotine withdrawal symptoms. In this randomized single-blind study, 91 cigarette smokers were randomly assigned to a single 1 mg dose of active nicotine nasal spray (n=29), active 4 mg nicotine gum (n=31), saline placebo nasal spray (n=16) or placebo gum (n=15). Following overnight abstinence, subjects repeatedly completed visual analog scales for assessing nicotine withdrawal symptoms over 30 min preceding (time -30 min to time 0) and 120 min following a single dose of study medication. This sequence was performed 3 times during the day. Nicotine withdrawal symptoms were assessed on a 41-point visual analog scale (1=no withdrawal, 41=extreme withdrawal). At the initial session only, blood samples for serum nicotine levels were taken at baseline, then at 5, 10, 30 and 120 min following study drug administration. The mean (+/-SD) age of the subjects was 38.6 (+/-10.1) years, 48% were females, smoking rate was 24.5 (+/-7.8) cigarettes per day, and years of smoking was 19.9 (+/-10.0). A single 1 mg dose of nicotine nasal spray provided more immediate relief for craving for a cigarette compared to a single 4 mg dose of nicotine gum. Serum venous nicotine levels for the active nicotine nasal spray and nicotine gum were comparable at 5 and 10 min while the levels were higher for nicotine gum at 30 and 120 min. Changes in withdrawal symptoms were not found to be related to serum venous nicotine levels. Our findings provide a rationale for the as needed use of nicotine nasal spray to control withdrawal symptoms, possibly in combination with other medications with longer acting effects.
已发现尼古丁鼻喷雾剂和尼古丁口香糖在缓解尼古丁戒断症状方面有效。在这项随机单盲研究中,91名吸烟者被随机分配至单剂量1毫克的活性尼古丁鼻喷雾剂组(n = 29)、活性4毫克尼古丁口香糖组(n = 31)、生理盐水安慰剂鼻喷雾剂组(n = 16)或安慰剂口香糖组(n = 15)。经过一夜戒烟后,受试者在单次服用研究药物前30分钟(时间-30分钟至时间0)和之后120分钟内,多次完成视觉模拟量表以评估尼古丁戒断症状。此过程在一天内进行3次。尼古丁戒断症状通过41分视觉模拟量表进行评估(1分=无戒断,41分=极度戒断)。仅在初始阶段,在基线时采集血样以测定血清尼古丁水平,然后在服用研究药物后的5、10、30和120分钟采集血样。受试者的平均(±标准差)年龄为38.6(±10.1)岁,48%为女性,吸烟率为每天24.5(±7.8)支香烟,吸烟年限为19.9(±10.0)年。与单剂量4毫克的尼古丁口香糖相比,单剂量1毫克的尼古丁鼻喷雾剂能更迅速地缓解对香烟的渴望。活性尼古丁鼻喷雾剂和尼古丁口香糖的血清静脉尼古丁水平在5和10分钟时相当,而在30和120分钟时尼古丁口香糖的水平更高。未发现戒断症状的变化与血清静脉尼古丁水平有关。我们的研究结果为按需使用尼古丁鼻喷雾剂来控制戒断症状提供了理论依据,可能与其他具有长效作用的药物联合使用。